Berkeley Group Earnings: Undersupplied London Real Estate Market To Support Fiscal 2024 Performance
Berkeley Group BKG continues to traverse the challenging U.K. housing market conditions of 2023 with relative ease. The no-moat homebuilder delivered full-year fiscal 2023 pretax profit of GBP 604 million, broadly aligning with our expectations and its prior guidance. Homeowner demand for Berkeley’s brownfield redevelopment projects has to date remained largely impervious to the cyclical waning of the U.K. housing cycle in 2023, owing to its focus on brownfield redevelopment projects in the undersupplied housing markets of London and southeast England. Indeed, Berkeley retains a robust forward order book—of about GBP 2.1 billion heading into fiscal 2024—that positions Berkeley well as it navigates the cyclical decline in homebuyer appetite and house price headwinds that presently exist. By contrast, 2023 and 2024 are shaping up as a challenging period for volume homebuilders in the U.K. with forward orders falling dramatically in response to the rapid tightening of financial conditions since late 2022.
Entering fiscal 2024 in a position of relative strength, Berkeley remains confident in delivering GBP 1.05 billion in cumulative pretax earnings over the fiscal 2024-25 period. Consequently, our near- and long-term expectations are unchanged. Berkeley shares screen as undervalued, trading at a 19% discount to our unchanged GBX 4,800 fair value estimate. Still, we see greater value elsewhere within the sector with the equity market appreciating the strength of Berkeley’s forward order book at a point of cyclical weakness. No-moat Persimmon is our top pick within our U.K. homebuilder coverage.
Broadly speaking, the U.K. homebuilding industry faces a difficult 2023 where profit margins are coming under considerable pressure from a combination of soaring build cost inflation and the effects of a cyclically declining housing market, which is causing home completion volumes to contract sharply and also placing pressure on house prices.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.